In the pooled analysis , risk was increased with HT versus placebo in women with MetS ( odds ratio , 2.26 ; 95 % CI , 1.26-4 .07 ) , whereas women without MetS were not found to have an increased risk for a CHD event with HT ( odds ratio , 0.97 ; 95 % CI , 0.58-1 .61 ; P for interaction = 0.03 ) .
